Organization
Immunoscience Development Center, Abbott Laboratories
2 abstracts
Abstract
ADALIMUMAB (HUMIRA®) PLUS METHOTREXATE PROVIDES SUSTAINED IMPROVEMENTS IN PHYSICAL FUNCTION OVER 2 YEARS OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: Abbott Laboratories, Immunoscience Development Center, Abbott Laboratories,
Abstract
ADALIMUMAB (HUMIRA®) PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: CONTINUED EFFICACY UP TO 4 YEARS IN OPEN-LABEL TRIALSOrg: Denver Arthritis Clinic, Cedars-Sinai Medical Center, UCLA Department of Medicine, Center for Innovative Therapy, UCSD, San Diego, CA,